{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T01:18:26Z","timestamp":1769476706522,"version":"3.49.0"},"reference-count":43,"publisher":"FapUNIFESP (SciELO)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ci\u00eanc. sa\u00fade coletiva"],"abstract":"<jats:p>Abstract Chronic non-communicable diseases (NCDs) significantly contribute to global mortality and diminished quality of life, placing a growing burden on healthcare systems. The World Health Organization has developed cost-effective strategies to manage these diseases, entitled \u201cbest buys\u201d, by addressing major risk factors for NCDs, such as smoking, alcohol use, unhealthy diets, and physical inactivity. Pharmacies, as accessible healthcare facilities, are well-positioned to support preventive care and behaviour change, including tobacco and alcohol cessation, dietary modifications, and physical activity promotion. Legislation in some countries, like Portugal, empowers pharmacies to deliver health promotion services to the communities they serve. Strengthening collaboration between pharmacies, other healthcare services, and public health authorities can amplify the impact of these initiatives, improving population health outcomes.<\/jats:p>","DOI":"10.1590\/1413-81232026311.14152025","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T15:13:50Z","timestamp":1769440430000},"source":"Crossref","is-referenced-by-count":0,"title":["What are the \u201cbest-buys\u201d for health promotion in pharmacy?"],"prefix":"10.1590","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8518-3277","authenticated-orcid":false,"given":"Ruben","family":"Viegas","sequence":"first","affiliation":[{"name":"University of Lisbon,  Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3806-438X","authenticated-orcid":false,"given":"Romeu","family":"Mendes","sequence":"additional","affiliation":[{"name":"University Porto,  Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0562-2514","authenticated-orcid":false,"given":"Filipa Alves da","family":"Costa","sequence":"additional","affiliation":[{"name":"University of Lisbon,  Portugal"}]}],"member":"530","published-online":{"date-parts":[[2026,1]]},"reference":[{"key":"ref1","series-title":"Noncommunicable diseases [Internet]","year":"2023"},{"issue":"10331","key":"ref2","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0140-6736(22)00567-0","article-title":"Non-communicable diseases what now?","volume":"399","year":"2022","journal-title":"Lancet"},{"key":"ref3","series-title":"Global status report on noncommunicable diseases 2010","year":"2010"},{"key":"ref4","series-title":"NCD Global Monitoring Framework","year":"2011"},{"key":"ref5","series-title":"Tackling NCDs: best buys and other recommended interventions for the prevention and control of noncommunicable diseases","year":"2017"},{"key":"ref6","series-title":"Updated Appendix 3 of the WHO global NCD action plan 2013-2030","year":"2022"},{"key":"ref7","series-title":"Tackling NCDs: best buys and other recommended interventions for the prevention and control of noncommunicable diseases","year":"2024","edition":"2"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"101281","DOI":"10.1016\/j.lanepe.2025.101281","article-title":"Quick buys for prevention and control of noncommunicable diseases","volume":"52","author":"Galea G","year":"2025","journal-title":"Lancet Reg Health Eur"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4103\/jehp.jehp_1374_20","article-title":"Health-promoting services provided in pharmacies a systematic review","volume":"10","author":"Shirdel A","year":"2021","journal-title":"J Educ Health Promot"},{"issue":"7","key":"ref10","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.sapharm.2019.10.008","article-title":"Beating non-communicable diseases in primary health care the contribution of pharmacists and guidance from FIP to support WHO goals","volume":"16","author":"Sousa Pinto G","year":"2020","journal-title":"Res Soc Adm Pharm"},{"key":"ref11","series-title":"Integrated brief interventions for noncommunicable disease risk factors in primary care: the manual: BRIEF project","year":"2022"},{"key":"ref12","series-title":"Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy","first-page":"557","volume-title":"Evidence of the impact of smoking cessation","author":"Cavaco Silva P","year":"2023"},{"key":"ref13","first-page":"CD003698","article-title":"Community pharmacy personnel interventions for smoking cessation","volume":"10","author":"Carson Chahhoud KV","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"ref14","first-page":"143","article-title":"Smoking cessation at the community pharmacy determinants of success from a real-life practice","volume":"9","author":"Condinho M","year":"2021","journal-title":"Pharmacy (Basel)"},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1016\/j.sapharm.2022.01.008","article-title":"Effects of educational interventions on the smoking cessation service provided by community pharmacists a systematic review","volume":"18","author":"Appalasamy JR","year":"2022","journal-title":"Res Soc Adm Pharm"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.sapharm.2023.09.003","article-title":"Smoking cessation intervention in the community pharmacy: Cost-effectiveness of a non-randomized cluster-controlled trial at 12-months' follow-up","volume":"20","author":"G\u00f3mez Mart\u00ednez JC","year":"2024","journal-title":"Res Social Adm Pharm"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/jcpt.12131","article-title":"Meta-analysis of the effectiveness of smoking cessation interventions in community pharmacy","volume":"39","author":"Saba M","year":"2014","journal-title":"J Clin Pharm Ther"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009828","article-title":"Community pharmacy-delivered interventions for public health priorities a systematic review of interventions for alcohol reduction, smoking cessation and weight management, including meta-analysis for smoking cessation","volume":"6","author":"Brown TJ","year":"2016","journal-title":"BMJ Open"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1186\/s12889-016-3805-3","article-title":"'Making the invisible visible' through alcohol screening and brief intervention in community pharmacies: an Australian feasibility study","volume":"16","author":"Hattingh HL","year":"2016","journal-title":"BMC Public Health"},{"key":"ref20","first-page":"21","article-title":"Pharmacy-based alcohol-misuse services current perspectives","volume":"7","author":"Hattingh HL","year":"2018","journal-title":"Integr Pharm Res Pract"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1111\/add.12994","article-title":"The effectiveness of brief alcohol interventions delivered by community pharmacists randomized controlled trial","volume":"110","author":"Dhital R","year":"2015","journal-title":"Addiction"},{"key":"ref22","first-page":"21","article-title":"Pharmacy-based alcohol-misuse services current perspectives","volume":"7","author":"Hattingh HL","year":"2017","journal-title":"Integr Pharm Res Pract"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"m2482","DOI":"10.1136\/bmj.m2482","article-title":"Food is medicine actions to integrate food and nutrition into healthcare","volume":"369","author":"Downer S","year":"2020","journal-title":"BMJ"},{"key":"ref24","series-title":"Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy","first-page":"485","volume-title":"Evidence of the Impact of Interventions to Prevent Obesity","author":"Caneiras C","year":"2023"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"100145","DOI":"10.1016\/j.ajpc.2020.100145","article-title":"The food pharmacy theory, implementation, and opportunities","volume":"5","author":"Donohue JA","year":"2021","journal-title":"Am J Prevent Cardiol"},{"issue":"1","key":"ref26","first-page":"274","article-title":"Community Pharmacy-Delivered Interventions for Nutrition and Diet-Related Health Promotion","volume":"91","author":"Acar G","year":"2023","journal-title":"Proceedings"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"102058","DOI":"10.1016\/j.japh.2024.102058","article-title":"Effect of pharmacist interventions on the management of overweight and obesity a systematic review","volume":"64","author":"Alhomoud IS","year":"2024","journal-title":"J Am Pharm Assoc"},{"key":"ref28","series-title":"Decreto-Lei n\u00ba 62\/2016, de 12 de setembro","first-page":"3154","year":"2016"},{"key":"ref29","series-title":"Portaria n\u00ba 97\/2018, de 9 de abril","first-page":"1556","year":"2018"},{"key":"ref30","series-title":"Promoting physical activity through primary health care: a toolkit","year":"2021"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/eurpub\/ckae015","article-title":"Pharmacists' involvement in physical activity promotion in community pharmacy a systematic review","volume":"34","author":"Viegas R","year":"2024","journal-title":"Eur J Public Health"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.sapharm.2023.12.003","article-title":"Physical activity promotion in the community pharmacy an opportunity for an expanded role?","volume":"20","author":"Viegas R","year":"2024","journal-title":"Res Soc Admin Pharmacy"},{"key":"ref33","series-title":"Healthy Living Pharmacies","year":"2019"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s11096-012-9634-2","article-title":"Review of services provided by pharmacies that promote healthy living","volume":"34","author":"Brown D","year":"2012","journal-title":"Int J Clin Pharm"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","DOI":"10.24926\/iip.v12i4.4370","article-title":"Expanding Pharmacy Services to Support Public Health","volume":"12","author":"DiPietro Mager N","year":"2021","journal-title":"Innov Pharm"},{"key":"ref36","series-title":"Despacho n\u00ba 199\/2016","year":"2016"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.healthpol.2013.04.003","article-title":"Expanding the role of community pharmacists Policymaking in the absence of policy-relevant evidence?","volume":"111","author":"Mossialos E","year":"2013","journal-title":"Health Policy"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/pubmed\/fdg030","article-title":"Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease","volume":"25","author":"Blenkinsopp A","year":"2003","journal-title":"J Public Health Med"},{"key":"ref39","series-title":"Portaria n\u00ba 206\/2024\/1, de 12 de setembro","first-page":"4","year":"2024"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"107019","DOI":"10.1016\/j.ejps.2025.107019","article-title":"The impact of community pharmacies on equity in access to professional rapid antigen testing for SARS-CoV-2 in Portugal","volume":"206","author":"Guerreiro J","year":"2025","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/1715163520915744","article-title":"Costs and consequences of the Portuguese needle-exchange program in community pharmacies","volume":"153","author":"Borges M","year":"2020","journal-title":"Can Pharm J (Ott)"},{"issue":"4","key":"ref42","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s11096-021-01301-7","article-title":"Pharmacists' involvement in COVID-19 vaccination across Europe a situational analysis of current practice and policy","volume":"43","author":"Paudyal V","year":"2021","journal-title":"Int J Clin Pharm"},{"key":"ref43","series-title":"Health at a Glance: Europe 2024: State of Health in the EU Cycle","year":"2024"}],"container-title":["Ci\u00eancia &amp; Sa\u00fade Coletiva"],"original-title":["Quais s\u00e3o as \u201cmelhores compras\u201d para a promo\u00e7\u00e3o da sa\u00fade nas farm\u00e1cias?"],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S1413-81232026000101822&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T15:13:55Z","timestamp":1769440435000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1413-81232026000101822&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["S1413-81232026000101822"],"URL":"https:\/\/doi.org\/10.1590\/1413-81232026311.14152025","relation":{},"ISSN":["1678-4561","1413-8123"],"issn-type":[{"value":"1678-4561","type":"electronic"},{"value":"1413-8123","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"article-number":"e14152025"}}